Name: Novel pet Radiotracers With Potential Clinical Applications, an Issue of pet Clinics (Volume 12-3) (The Clinics: Radiology, Volume 12-3) (en Inglés)
Price: 86.52 USD
Availability: InStock
Author: Neil Vasdev Phd; Abass Alavi Md
ISBN: 9780323531443

portada Novel pet Radiotracers With Potential Clinical Applications, an Issue of pet Clinics (Volume 12-3) (The Clinics: Radiology, Volume 12-3) (en Inglés)

Novel pet Radiotracers With Potential Clinical Applications, an Issue of pet Clinics (Volume 12-3) (The Clinics: Radiology, Volume 12-3) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Neil Vasdev Phd; Abass Alavi Md

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323531443

N° edición

Novel pet Radiotracers With Potential Clinical Applications, an Issue of pet Clinics (Volume 12-3) (The Clinics: Radiology, Volume 12-3) (en Inglés)

Neil Vasdev Phd; Abass Alavi Md (Autor) · Elsevier · Tapa Dura

Libro Nuevo Importado

Envío: 23 a 30 días háb.

$ 157.31$ 86.52

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 86.52

Llega entre el 07 Sep y el 18 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Novel pet Radiotracers With Potential Clinical Applications, an Issue of pet Clinics (Volume 12-3) (The Clinics: Radiology, Volume 12-3) (en Inglés)"

This issue of PET Clinics focuses on Radiotracers, and is edited by Drs. Neil Vasdev and Abass Alavi. Articles will include: PET/CT detection of HER2-positive metastases in patients with 89Zr-DFO-trastuzumab; uPAR-PET with 68Ga-NOTA-AE105: first clinical experience with a novel PET ligand; 64Cu-FBP8: A fibrin-targeted probe for imaging of thrombus; Imaging of synaptic density in the brain via synaptic vesicle glycoprotein 2A (SV2A) with a novel biomarker [11C]UCB-J; Neuroimaging of stress sensitive and neuroinflammatory targets in mood disorders; Impact of MR-based PET motion correction on the quantification of PET kinetic parameters in simultaneous cardiac PET-MR; Multimodal studies of the contributions of amyloid and tau burden to neurodegeneration in AD, FTD and Non-AD tauopathies; Imaging of prostate-specific membrane antigen (PSMA) using [18F]DCFPyL; Ga-68 GRPR antagonist imaging; and more!